JUL 27, 2016 06:31 AM PDT

PET Scan to Visualize Synaptic Density in the Living Brain

WRITTEN BY: Cassidy Reich
Synapses are the connections between neurons that allow them to communicate with each other. When synapses become compromised and can no longer effectively communicate, they are lost, and brain function suffers. Synaptic density would be a great measure for diagnosis and for tracking neuropathology in certain diseases, but there is currently no way to look at synaptic density in the living brain. Evaluating synaptic density requires brain tissue from autopsy or surgical resection. However, scientists have developed a new radioligand for PET (positron emission tomography) scans that is capable of measuring synaptic density in the living brain.

There are ~100 trillion synapses in the human brain.
This research was recently published in Science Translational Medicine and described PET studies with a new radioligand that were conducted in non-human primates, healthy human subjects, and epileptic patients with mesial temporal lobe sclerosis.

Usually when measuring synaptic density in brain tissue, researchers will use an antibody against synaptophysin, a protein that is present in every single presynaptic vesicle. However, there is currently no radioligand that can be used for PET that binds to synaptophysin. The company UCB does have an antiepileptic drug, levetiracetam, that targets another synaptic vesicle protein, SV2A. A derivative of this drug, [11C]UCB-J, is the radioligand that was tested in these studies and has been shown to specifically bind to SV2A. SV2A, just like synaptophysin, is present in every synapse.

When they tested [11C]UCB-J in non-human primates, they saw a signal in gray matter and none in white matter, which makes sense. Gray matter consists of the axons and dendrites of neurons, i.e. where the synapses are, and white matter is the cell bodies of those neurons. To investigate the quantitative nature of their tracer, the scientists also cross-validated PET signals with post-mortem brain tissue analysis of SV2A protein levels in several brain regions.

Following non-human primate studies, [11C]UCB-J was tested in healthy human subjects and was found to be effective and had favorable kinetics. The real test was to do a PET scan with [11C]UCB-J in epileptic patients with mesial temporal lobe sclerosis. In patients with this condition, there is loss of synapses in the hippocampus in one hemisphere and the atrophy is also visible on MRI. With this new tracer, the scientists were able to visualize the loss in synaptic density in the hippocampus on the affected side compared to the unaffected side, and were also able to correlate the synapse loss with degree of atrophy.  


This is a crazy advancement for neuroimaging because synapse loss is present in so many neurological conditions and is also one of the pathological events in Alzheimer’s disease (AD) that closely tracks with cognitive decline. When neurons die, they die, and there is no getting them back. But it might be possible to reverse damage to the synapses which is the step that precedes neuronal loss in AD. Which this kind of imaging, it will be possible to monitor the effect of early interventions in AD on synaptic density, a measure that correlates with cognitive decline more so than other biological markers.

I have barely scratched the surface, and if you are interested, I strongly suggest looking at the original article in Science Translational Medicine and also this great write-up on AlzForum.
About the Author
  • Cassidy is a curious person, and her curiosity has led her to pursue a PhD in Pharmacology at the New York University Sackler Institute of Biomedical Sciences. She likes to talk about science way too much, so now she's going to try writing about it.
You May Also Like
NOV 06, 2018
Cannabis Sciences
NOV 06, 2018
The Role of Endocannabinoids in Orgasm
Now that I've got your attention, we can talk science now. Yes, there is actually relatively new study which measures levels of endocannabinoids in blo...
DEC 05, 2018
Cardiology
DEC 05, 2018
The Case For Sexual Healing In Heart Patients
Sex is an important component in the lives of most healthy adults. As such, it is essential for providers working with post-coronary patients to advise the...
NOV 26, 2018
Neuroscience
NOV 26, 2018
Ventromedial Prefrontal Cortex Central For Imagination Mitigated Fear
Extinction; presenting fear in a neutral setting where the negative consequences are negated is one of the successful fear conditioning mechanisms...
DEC 18, 2018
Health & Medicine
DEC 18, 2018
Gender Dysphoria
  Gender dysphoria is a distressing conflict for a person whose sexual identity is different than that assigned at birth. Previously called gende...
DEC 17, 2018
Health & Medicine
DEC 17, 2018
Zapping the Vagus Nerve for Weight Loss Becomes Smaller
In laboratory testing, the devices helped rats shed almost 40 percent of their body weight. Results of the study were published today (Dec. 17, 2018) in the journal Nature Communications....
JAN 16, 2019
Cannabis Sciences
JAN 16, 2019
Effects of Low Cannabis Use in Teens on the Brain
A recent article published in the Journal of Neuroscience presents more data to suggest that marijuana use in adolescents is harmful to brain development a...
Loading Comments...